Stenotrophomonas maltophilia drug resistance

Future Microbiology

Volumn 4, Issue 6, 2009, Pages 655-660

  Sanchez, Maria B ^a,b   Hernandez, Alvaro ^a,b   Martinez, Jose L ^a,b  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Antibiotic resistance; Intrinsic resistance; MDR; Multidrug resistance; Qnr; Stenotrophomonas maltophilia

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEMASE; CHLORAMPHENICOL ACETYLTRANSFERASE; CLAVULANIC ACID; CLINAFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; MINOCYCLINE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TIMENTIN; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL VIRULENCE; GENE MUTATION; GRAM NEGATIVE INFECTION; HORIZONTAL GENE TRANSFER; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENES, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; STENOTROPHOMONAS MALTOPHILIA;

BACTERIA (MICROORGANISMS); STENOTROPHOMONAS MALTOPHILIA;

EID: 69849097479     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.45     Document Type: Article

References (34)

1. Ribbeck-Busch K, Roder A, Hasse D et al.: A molecular biological protocol to distinguish potentially human pathogenic Stenotrophomonas maltophilia from plant-associated Stenotrophomonas rhizophila. Environ. Microbiol. 7(11), 1853-1858 (2005).
2. Looney WJ, Narita M, Muhlemann K: Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9(5), 312-323 (2009).
3. Morales G, Wiehlmann L, Gudowius P et al.: Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J. Bacteriol. 186(13), 4228-4237 (2004).
4. Alonso A, Rojo F, Martinez JL: Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ. Microbiol. 1(5), 421-430 (1999).
5. Gould VC, Okazaki A, Howe RA, Avison MB: Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates. J. Antimicrob. Chemother. 54(2), 348-353 (2004).
6. Berg G, Roskot N, Smalla K: Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J. Clin. Microbiol. 37(11), 3594-3600 (1999).
7. Crossman LC, Gould VC, Dow JM et al.: The complete genome, comparative and functional ana lysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 9(4), R74 (2008).
8. Martinez JL, Fajardo A, Garmendia L et al.: A global view of antibiotic resistance. FEMS Microbiol. Rev. 33(1), 44-65 (2009).
9. Martinez JL: Antibiotics and antibiotic resistance genes in natural environments. Science 321(5887), 365-367 (2008).
10. Vila J, Martinez JL: Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of ef?ux pump inhibitors. Curr. Drug Targets 9(9), 797-807 (2008).
11. Zhang L, Li XZ, Poole K: Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob. Agents Chemother. 44(2), 287-293 (2000).
12. Alonso A, Martinez JL: Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44(11), 3079-3086 (2000).
13. Li XZ, Zhang L, Poole K: SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 46(2), 333-343 (2002).
14. Alonso A, Martinez JL: Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45(6), 1879-1881 (2001).
15. Zhang L, Li XZ, Poole K: SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45(12), 3497-3503 (2001).
16. Avison MB, Higgins CS, Ford PJ et al.: Differential regulation of L1 and L2 β-lactamase expression in Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 49(2), 387-389 (2002).
17. Okazaki A, Avison MB: Induction of L1 and L2 β-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob. Agents Chemother. 52(4), 1525-1528 (2008).
18. Okazaki A, Avison MB: Aph(3′)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 51(1), 359-360 (2007).
19. Li XZ, Zhang L, McKay GA, Poole K: Role of the acetyltransferase AAC(6′)-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 51(4), 803-811 (2003).
20. Sánchez MB, Hernández A, Rodríguez-Martínez JM, Martínez-Martínez L, Martínez JL: Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol. 8, 148 (2008).
21. Alonso A, Sanchez P, Martinez JL: Stenotrophomonas maltophilia D457R contains a cluster of genes from Gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob. Agents Chemother. 44(7), 1778-1782 (2000).
22. Chang LL, Chen HF, Chang CY, Lee TM, Wu WJ: Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 53(3), 518-521 (2004).
23. Toleman MA, Bennett PM, Bennett DM, Jones RN, Walsh TR: Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg. Infect. Dis. 13(4), 559-565 (2007).
24. Avison MB, von Heldreich CJ, Higgins CS, Bennett PM, Walsh TR: A TEM-2β-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 46(6), 879-884 (2000).
25. Shimizu K, Kikuchi K, Sasaki T et al.: Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 52(10), 3823-3825 (2008).
26. Ribera A, Doménech-Sanchez A, Ruiz J, Benedi VJ, Jimenez de Anta MT, Vila J: Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Microb. Drug Resist. 8(4), 245-251 (2002).
27. Ba BB, Feghali H, Arpin C, Saux MC, Quentin C: Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob. Agents Chemother. 48(3), 946-953 (2004).
28. Sanchez P, Moreno E, Martinez JL: The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob. Agents Chemother. 49, 781-782 (2005).
29. Hernández A, Maté MJ, Sánchez-Díaz PC, Romero A, Rojo F, Martínez JL: Structural and functional analysis of SmeT, the repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. J. Biol. Chem. 284(21), 14428-14438 (2009).
30. Martinez JL, Baquero F, Andersson DI: Predicting antibiotic resistance. Nat. Rev. Microbiol. 5(12), 958-965 (2007).
31. Anderson SW, Stapp JR, Burns JL, Qin X: Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. J. Clin. Microbiol. 45(2), 529-535 (2007).
32. Passerini de Rossi B, García C, Calenda M, Vay C, Franco M: Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections. Int. J. Antimicrob. Agents doi: 10.1016/j.ijantimicag.2009.02.022 (2009) (In Press).
33. Ryan RP, Monchy S, Cardinale M: The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 7(7), 514-525 (2009).
34. Alonso A, Morales G, Escalante R, Campanario E, Sastre L, Martinez JL: Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J. Antimicrob. Chemother. 53(3), 432-434 (2004).